Cell Receptor Information

Cell Receptor also provides insights into pharmacologically useful substances that can inhibit these mechanisms. Based on this, methods were developed for the prevention of cancer metastases and for the suppression of undesired proliferative processes, for example in the immune system. The company owns significant intellectual property for this. Our patents concern the blocking of the transport process by substances that we have found to be effective. We are convinced that the clinical demand will be quite substantial. Cell Receptor is now planning a clinical trial in collaboration with a renowned hospital as proof of concept. In the sense of repurposing, a substance that we have recognized as effective and that has already been approved will be used.